换一批mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis.
第一作者：
Catarina,Träger
第一单位：
Childhood Cancer Research Unit, Department of Woman and Child Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. catarina.trager@ki.se
作者：
医学主题词
青少年(Adolescent);骨髓(Bone Marrow);病例对照研究(Case-Control Studies);细胞系, 肿瘤(Cell Line, Tumor);儿童(Child);儿童, 学龄前(Child, Preschool);多巴脱羧酶(Dopa Decarboxylase);女(雌)性(Female);基因表达调控, 酶学(Gene Expression Regulation, Enzymologic);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);婴儿(Infant);婴儿, 新生(Infant, Newborn);男(雄)性(Male);N-乙酰氨基半乳糖转移酶类(N-Acetylgalactosaminyltransferases);肿瘤分期(Neoplasm Staging);神经母细胞瘤(Neuroblastoma);试验预期值(Predictive Value of Tests);预后(Prognosis);结果可重复性(Reproducibility of Results);逆转录聚合酶链反应(Reverse Transcriptase Polymerase Chain Reaction);危险性评估(Risk Assessment);危险因素(Risk Factors);敏感性与特异性(Sensitivity and Specificity);瑞典(Sweden);治疗结果(Treatment Outcome);酪氨酸单氧化酶(Tyrosine 3-Monooxygenase)
DOI
10.1002/ijc.23846
PMID
18814238
发布时间
2016-03-03
- 浏览28
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
